Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Nov 5, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
An2 Therapeutics, Inc.
| 10.13K |
—
|
—
| +40.15% | 35.34K |
Nov 4
| |||||||
An2 Therapeutics, Inc.
| 31.5K |
—
|
—
| +33.22% | 126.33K |
Nov 4
| |||||||
An2 Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
An2 Therapeutics, Inc.
| 1.5M |
$1.04 | $1,560,000.00 | +35.30% | 5.75M |
Aug 14
| |||||||
An2 Therapeutics, Inc.
| -3.53M |
$1.08 | -$3,807,101.52 | -63.50% | 2.03M |
Aug 9
| |||||||
An2 Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
An2 Therapeutics, Inc.
| 60K |
—
|
—
| +172.25% | 94.83K |
Jul 10
| |||||||
An2 Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 19
| |||||||
An2 Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 19
| |||||||
An2 Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 19
| |||||||
An2 Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 19
| |||||||
An2 Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 19
| |||||||
An2 Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 19
| |||||||
An2 Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 19
| |||||||
An2 Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 19
| |||||||
An2 Therapeutics, Inc.
| 30K |
—
|
—
| +140.08% | 51.42K |
Mar 15
| |||||||
An2 Therapeutics, Inc.
| 27.5K |
—
|
—
| +879.44% | 30.63K |
Mar 15
| |||||||
An2 Therapeutics, Inc.
| 30K |
—
|
—
| +1,225.99% | 32.45K |
Mar 15
| |||||||
An2 Therapeutics, Inc.
| 30K |
—
|
—
| +1,567.40% | 31.91K |
Mar 15
| |||||||
An2 Therapeutics, Inc.
| 27.5K |
—
|
—
| +3,741.50% | 28.23K |
Mar 15
| |||||||
An2 Therapeutics, Inc.
| 99K |
—
|
—
| +4,647.89% | 101.13K |
Mar 15
| |||||||
An2 Therapeutics, Inc.
| 27.5K |
—
|
—
| +879.44% | 30.63K |
Mar 15
| |||||||
An2 Therapeutics, Inc.
| 30K |
—
|
—
| +1,225.99% | 32.45K |
Mar 15
| |||||||
An2 Therapeutics, Inc.
| 30K |
—
|
—
| +1,567.40% | 31.91K |
Mar 15
| |||||||
An2 Therapeutics, Inc.
| 27.5K |
—
|
—
| +3,741.50% | 28.23K |
Mar 15
| |||||||
An2 Therapeutics, Inc.
| 30K |
—
|
—
| +140.08% | 51.42K |
Mar 15
| |||||||
An2 Therapeutics, Inc.
| 99K |
—
|
—
| +4,647.89% | 101.13K |
Mar 15
| |||||||
-100.00K |
$19.11 | -$1,911,410.00 | -19.77% | 405.88K |
Jan 18
| ||||||||
-100.00K |
$19.65 | -$1,965,000.00 | -4.04% | 2.37M |
Jan 16
| ||||||||
-100.00K |
$19.65 | -$1,965,000.00 | -4.04% | 2.37M |
Jan 16
| ||||||||
-1.43K |
$21.92 | -$31,228.81 | -0.16% | 899.86K |
Jan 12
|
Scheduled
| |||||||
-3.67K |
$21.93 | -$80,443.17 | -0.41% | 901.29K |
Jan 10
|
Scheduled
| |||||||
0
|
$12.37 | -$115,352.11 |
—
| 1.91K |
Jan 9
| ||||||||
0
|
$10.27 | -$50,882.26 |
—
| 1.91K |
Jan 2
| ||||||||
-2.78K |
$20.09 | -$55,802.43 | -56.59% | 2.13K |
Jan 2
| ||||||||
-1.81K |
$16.15 | -$29,224.26 | -0.07% | 2.47M |
Nov 14
| ||||||||
-1.81K |
$16.15 | -$29,224.26 | -0.07% | 2.47M |
Nov 14
| ||||||||
An2 Therapeutics, Inc.
| -104.77K |
$16.27 | -$1,704,513.32 | -4.06% | 2.48M |
Sep 29 - Oct 2
| |||||||
An2 Therapeutics, Inc.
| -104.77K |
$16.27 | -$1,704,513.32 | -4.06% | 2.48M |
Sep 29 - Oct 2
| |||||||
An2 Therapeutics, Inc.
| -9.36K |
$16.11 | -$150,707.63 | -0.36% | 2.58M |
Sep 27 - Sep 28
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.